Cancer Chemotherapy near the End of Life: The Time has come to set Guidelines for its Appropriate Use
- 1 September 2007
- journal article
- research article
- Published by SAGE Publications in Tumori Journal
- Vol. 93 (5), 417-422
- https://doi.org/10.1177/030089160709300502
Abstract
Aims and Background This study retrospectively analyzes the use of chemotherapy in patients who died of advanced cancer either after having been in care at the Medical Oncology Unit (MOU) of the University Hospital of Bologna, Italy, or after having been assisted in their terminal disease phase by the Bologna Oncological Hospice at Home (OHH) of the Associazione Nazionale Tumori (ANT) Italia Foundation. In the latter group, the prescription and delivery of chemotherapy had been performed by doctors of medical oncology departments other than the MOU. Results Between January 2003 and September 2005, 793 deaths of patients were recorded (MOU: 312; OHH: 481). At least one cycle of chemotherapy had been received by 445 patients (56.1%). The most common cancer types were lung cancer (26.7%), colorectal cancer (14.8%), and breast cancer (11.2%). At the time of the last chemotherapy (l-CT), the median age of the patients was 68 years (range, 22–98 years) and the median KPS was 70 (range, 40–100). The median interval between l-CT and death was 71 days (range, 1-1913 days). One hundred and one patients (22.7%) had received their l-CT in the last 30 days of their life, 86% of them having intermediately chemosensitive (71%) or chemoresistant (14%) tumors. The l-CT in the last month of life was first line in 56% of cases and consisted of costly new-generation drugs in 36.6% of cases. Conclusions The study suggests the urgent need to lay down guidelines for the appropriate use of chemotherapy in advanced cancer patients with a short life expectancy.Keywords
This publication has 12 references indexed in Scilit:
- Do Unto Others…Journal of Clinical Oncology, 2006
- Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From CancerJournal of Clinical Oncology, 2006
- Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative CareJournal of Clinical Oncology, 2005
- Bridging the Divide: Integrating Cancer-Directed Therapy and Palliative CareJournal of Clinical Oncology, 2004
- Trends in the Aggressiveness of Cancer Care Near the End of LifeJournal of Clinical Oncology, 2004
- Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choiceBritish Journal of Cancer, 2003
- A systematic review of physicians' survival predictions in terminally ill cancer patientsBMJ, 2003
- Chemotherapy Use among Medicare Beneficiaries at the End of LifeAnnals of Internal Medicine, 2003
- Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study Commentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuitionBMJ, 2000
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998